Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Study of Unplanned Hospitalization and Emergency Department Use in Patients With Head and Neck Cancer Receiving Radiotherapy: Incidence, Factors and Development of a Risk Prediction Model

NCT07929194 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07929194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Study of Unplanned Hospitalization and Emergency Department Use in Patients With Head and Neck Cancer Receiving Radiotherapy: Incidence, Factors and Development of a Risk Prediction Model
Lead sponsor
Xiangya Hospital of Central South University
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
August 12, 2028
Enrollment
657 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 1 arm.

  • HNC Patients Receiving IMRT

    Consecutive adults with histologically confirmed head and neck cancer scheduled for intensity-modulated radiotherapy (IMRT/VMAT), with or without concurrent chemotherapy or targeted therapy, enrolled before radiotherapy and followed from the first treatment fraction through 30 days after treatment completion. No study-assigned intervention is provided; all patients receive standard clinical care.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Incidence of Unplanned Hospitalization From Day 1 of radiotherapy fraction through 30 days after radiotherapy completion (approximately 3 months)

    Proportion of participants with at least one unplanned inpatient admission, defined as any unscheduled inpatient admission encompassing (i) outpatient-to-inpatient transfer during radiotherapy, (ii) emergency department-led admission, and (iii) readmission after treatment discharge; planned elective admissions are excluded.

Lead sponsor's other trials

Xiangya Hospital of Central South University, most recent start first.

Similar trials

Same condition (Head and Neck Neoplasms) and phase, most recent start first.